Neumora Therapeutics
About:
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Website: https://neumoratx.com/
Top Investors: Alexandria Venture Investments, F-Prime Capital, ARCH Venture Partners, Amgen, Invus
Description:
Neumora Therapeutics operates as a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience.
Total Funding Amount:
$612M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Watertown, Massachusetts, United States
Founded Date:
2019-01-01
Founders:
Carol Suh, Mike Poole, Paul L Berns
Number of Employees:
101-250
Last Funding Date:
2022-10-11
IPO Status:
Public
© 2025 bioDAO.ai